News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Greenlights Becton, Dickinson and Company (BDX) Syringes; Wilson Plant to Manufacture Product


3/27/2013 7:58:38 AM

Becton, Dickinson and Co. just netted FDA approval for a manufactured line of generic injectables aimed at reducing the potential for error. Through a wholly owned subsidiary called BD Rx, the new line of generic prefilled syringes will be manufactured at BD (NYSE: BDX)’s Wilson facility. The products, labeled BD Simplist, are designed to decrease the number of steps in the traditional vial and syringe injection sequence, thereby reducing the potential risk of medication error.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES